GSK Expects To Locally Produce 75% Of China-Sold Drugs Before 2014
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline PLC China plans to locally produce 75% of the drugs it sells in country by 2014, from 30% in 2009, according to general manager Mark Reilly.